Structure based design:: Novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors

被引：33
作者：
Ghosh, AK
Krishnan, K
Walters, DE
Cho, WH
Cho, H
Koo, Y
Trevino, J
Holland, L
Buthod, J
机构：
[1] Univ Illinois, Dept Chem, Chicago, IL 60607 USA
[2] Finch Univ Hlth Sci Chicago Med Sch, Dept Biol Chem, N Chicago, IL 60064 USA
[3] IIT, Res Inst, Dept Life Sci, Chicago, IL 60616 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 08期
关键词：
D O I：
10.1016/S0960-894X(98)00139-5
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel spirocyclic ethers were designed to function as nonpeptidal P-2-ligands for HIV-1 protease inhibitors. Incorporation of designed ligands in the (R)-(hydroxyethylamino)sulfonamide isostere afforded potent HIV protease inhibitors. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：979 / 982
页数：4
相关论文
共 19 条
  • [11] 3-TETRAHYDROFURAN AND PYRAN URETHANES AS HIGH-AFFINITY P2-LIGANDS FOR HIV-1 PROTEASE INHIBITORS
    GHOSH, AK
    THOMPSON, WJ
    MCKEE, SP
    DUONG, TT
    LYLE, TA
    CHEN, JC
    DARKE, PL
    ZUGAY, JA
    EMINI, EA
    SCHLEIF, WA
    HUFF, JR
    ANDERSON, PS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) : 292 - 294
  • [12] KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025
  • [13] ABT-538 IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE AND HAS HIGH ORAL BIOAVAILABILITY IN HUMANS
    KEMPF, DJ
    MARSH, KC
    DENISSEN, JF
    MCDONALD, E
    VASAVANONDA, S
    FLENTGE, CA
    GREEN, BE
    FINO, L
    PARK, CH
    KONG, XP
    WIDEBURG, NE
    SALDIVAR, A
    RUIZ, L
    KATI, WM
    SHAM, HL
    ROBINS, T
    STEWART, KD
    HSU, A
    PLATTNER, JJ
    LEONARD, JM
    NORBECK, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2484 - 2488
  • [14] CRYSTAL-STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME
    KIM, EE
    BAKER, CT
    DWYER, MD
    MURCKO, MA
    RAO, BG
    TUNG, RD
    NAVIA, MA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (03) : 1181 - 1182
  • [15] A USEFUL PREPARATION OF L-(S)-GLYCERALDEHYDE ACETONIDE
    MALONEYHUSS, KE
    [J]. SYNTHETIC COMMUNICATIONS, 1985, 15 (04) : 273 - 277
  • [16] RATIONAL DESIGN OF PEPTIDE-BASED HIV PROTEINASE-INHIBITORS
    ROBERTS, NA
    MARTIN, JA
    KINCHINGTON, D
    BROADHURST, AV
    CRAIG, JC
    DUNCAN, IB
    GALPIN, SA
    HANDA, BK
    KAY, J
    KROHN, A
    LAMBERT, RW
    MERRETT, JH
    MILLS, JS
    PARKES, KEB
    REDSHAW, S
    RITCHIE, AJ
    TAYLOR, DL
    THOMAS, GJ
    MACHIN, PJ
    [J]. SCIENCE, 1990, 248 (4953) : 358 - 361
  • [17] TOTH MV, 1990, INT J PEPT PROT RES, V36, P544
  • [18] L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
    VACCA, JP
    DORSEY, BD
    SCHLEIF, WA
    LEVIN, RB
    MCDANIEL, SL
    DARKE, PL
    ZUGAY, J
    QUINTERO, JC
    BLAHY, OM
    ROTH, E
    SARDANA, VV
    SCHLABACH, AJ
    GRAHAM, PI
    CONDRA, JH
    GOTLIB, L
    HOLLOWAY, MK
    LIN, J
    CHEN, IW
    VASTAG, K
    OSTOVIC, D
    ANDERSON, PS
    EMINI, EA
    HUFF, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4096 - 4100
  • [19] INHIBITORS OF HIV-1 PROTEASE CONTAINING THE NOVEL AND POTENT (R)-(HYDROXYETHYL)SULFONAMIDE ISOSTERE
    VAZQUEZ, ML
    BRYANT, ML
    CLARE, M
    DECRESCENZO, GA
    DOHERTY, EM
    FRESKOS, JN
    GETMAN, DP
    HOUSEMAN, KA
    JULIEN, JA
    KOCAN, GP
    MUELLER, RA
    SHIEH, HS
    STALLINGS, WC
    STEGEMAN, RA
    TALLEY, JJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (04) : 581 - 584
12